AMGN Imdelltra plus Imfinzi shows improved overall survival
Newsdesk says AMGN’s Imdelltra in combination with Imfinzi demonstrated landmark improvement in overall survival in first-line extensive-stage small cell lung cancer.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.